| P2093 | author name string | Fred A Weaver | |
| | Wesley K Lew | |
| | Sung W Ham | |
| P2860 | cites work | Exposure of mice to topical bovine thrombin induces systemic autoimmunity | Q28363428 |
| | A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis | Q34005378 |
| | Recombinant thrombin: safety and immunogenicity in burn wound excision and grafting | Q34016951 |
| | A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis | Q34018783 |
| | Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases | Q34206613 |
| | New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology | Q34262824 |
| | Fibrin sealants in surgical practice: An overview | Q34376135 |
| | Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product. | Q34418822 |
| | Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure | Q34564920 |
| | The clinical use and immunologic impact of thrombin in surgery | Q36467910 |
| | Preclinical safety of recombinant human thrombin | Q40232468 |
| | Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis | Q40732016 |
| | The use of local agents: Surgicel and Surgifoam | Q41440727 |
| | Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report | Q43810538 |
| | A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin: results of a randomized controlled trial | Q44886642 |
| | Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin | Q45162760 |
| | Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin | Q47301020 |
| | Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needle-hole bleeding from polytetrafluoroethylene femoral artery grafts | Q47441753 |
| | Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin | Q48373315 |
| | Comparison of a new fibrin sealant with standard topical hemostatic agents. | Q50781635 |
| | Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications. | Q51135382 |
| | Development of Antibodies to Bovine and Human Factor V in Two Children After Exposure to Topical Bovine Thrombin | Q59962679 |
| | Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin | Q68606264 |
| | Isolation and characterization of an acquired antithrombin antibody | Q68629745 |
| | Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery | Q69770529 |
| | Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients. Report of three cases | Q70649241 |
| | Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors | Q70699014 |
| | Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V | Q72311509 |
| | Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child | Q72455498 |
| | Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin | Q73352712 |
| | Antibodies to topical bovine thrombin correlate with access thrombosis | Q73740054 |
| | Blood coagulation | Q73814629 |
| | Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy | Q73850968 |
| | Antiphospholipid antibodies in left-ventricular assist system recipients after exposure to topical bovine thrombin | Q74615915 |
| | The use of human fibrin glue in the surgical operations | Q79847072 |
| | Severe coagulopathy following intraoperative use of topical thrombin | Q80539773 |
| | Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery | Q80610470 |
| | A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures | Q81162729 |
| | Antihuman factor V antibodies after use of relatively pure bovine thrombin | Q81447624 |
| | Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure | Q82771403 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 135-142 | |
| P577 | publication date | 2010-07-22 | |
| P1433 | published in | Journal of Blood Medicine | Q15817438 |
| P1476 | title | Thrombin use in surgery: an evidence-based review of its clinical use. | |
| P478 | volume | 1 | |